Figure 3
Figure 3. Increases in phosphorylated BLNK and PLC-γ induced by anti-μ in ZAP-70− CLL transduced with Ad-ZAP-70 or Ad-ZAP-70-KA369. The panels show the percentage increase in phosphorylated BLNK (A,C) and PLC-γ (B,D) induced by treatment with anti-μ, as indicated on the y-axis of each panel. Each symbol represents the percentage increase in phosphorylated protein detected in an individual CLL cell sample. The lines connect the percentage increase in detected phosphorylated protein of anti-μ–treated CLL cell samples transduced with Ad-lacZ (“Control” in each panel) versus that measured in the same CLL cells that had been transduced with Ad-ZAP-70 (A,B) or Ad-ZAP-70-KA369 (C,D). The mean anti-μ–induced increase in each phosphoprotein detected in the Ad-ZAP-70– or Ad-ZAP-70-KA369–transduced CLL cells was significantly greater than that noted for the same phosphoprotein in the Ad-lacZ–transduced CLL cells following treatment with anti-μ (P < .05), which was not significantly different from that of anti-μ–treated mock-transfected CLL cells.

Increases in phosphorylated BLNK and PLC-γ induced by anti-μ in ZAP-70 CLL transduced with Ad-ZAP-70 or Ad-ZAP-70-KA369. The panels show the percentage increase in phosphorylated BLNK (A,C) and PLC-γ (B,D) induced by treatment with anti-μ, as indicated on the y-axis of each panel. Each symbol represents the percentage increase in phosphorylated protein detected in an individual CLL cell sample. The lines connect the percentage increase in detected phosphorylated protein of anti-μ–treated CLL cell samples transduced with Ad-lacZ (“Control” in each panel) versus that measured in the same CLL cells that had been transduced with Ad-ZAP-70 (A,B) or Ad-ZAP-70-KA369 (C,D). The mean anti-μ–induced increase in each phosphoprotein detected in the Ad-ZAP-70– or Ad-ZAP-70-KA369–transduced CLL cells was significantly greater than that noted for the same phosphoprotein in the Ad-lacZ–transduced CLL cells following treatment with anti-μ (P < .05), which was not significantly different from that of anti-μ–treated mock-transfected CLL cells.

Close Modal

or Create an Account

Close Modal
Close Modal